Free radical biology & medicine · 2025
EMP1-driven ferroptosis in liver sinusoidal endothelial cells exacerbates hepatic ischemia-reperfusion injury via P38 MAPK.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Zhenyu, Wang Ziming, Huang Jingsheng, Luo Meiqi, Luo Xinling, Zeng Weiqi, Gao Yingxin, Huang Fei, Deng Zhizhao, Yuan Dongdong
Аннотация
Ischemia-reperfusion injury (IRI) remains the leading cause of early graft failure following liver transplantation (LT). Traditional paradigms have centered on hepatocyte death, yet the decisive contribution of liver sinusoidal endothelial cells (LSECs) as the first vascular barrier has long been overlooked. Here, single-cell RNA sequencing of human livers comparing normal controls with those exposed to transplantation-induced IRI, identified EMP1 as the most upregulated gene in LSECs. In LSECs and BRL3A hepatocytes subjected to hypoxia/reoxygenation (H/R), EMP1 silencing with an siRNA, ferroptosis modulation via ferrostatin-1 (Fer-1) or RSL3, and p38 signaling intervention using the p38 activator berberine chloride collectively revealed that EMP1 drives ferroptosis in LSECs in a p38-dependent manner. The results demonstrated that LSECs constituted the predominant hepatic endothelial population, whose numbers decline precipitously after transplantation. EMP1 emerged as the most markedly up-regulated gene in LSECs, correlating closely with the severity of injury. Silencing of EMP1 restored fenestral architecture, reduced VCAM-1 and E-selectin expression levels, suppressed Fe2+ accumulation and lipid peroxidation, down-regulated ACSL4, and reinstated GPX4, thereby halving the hepatocyte death effects phenocopied by Fer-1 and reversed by RSL3, confirming that ferroptosis as the central mechanism. Furthermore, EMP1 exerted its effects solely via p38 signaling and its depletion selectively abolished p38 phosphorylation, whereas the p38 activator berberine chloride fully reinstated ferroptotic phenotypes and hepatocyte injury. Collectively, these data establish EMP1/p38-driven LSEC ferroptosis as a direct cause of hepatocyte damage, offering a fundamentally new perspective on the pathogenesis of hepatic ischemia reperfusion injury (HIRI) and a novel, potentially targeted therapeutic strategy for its prevention and treatment.